SDS

_____________________________________________________________________________________________
1358919 - Camelion AA Alkaline Battery
Revision Date 03-Nov-2016
Lead
7439-92-1
A3 Group 2A Reasonably Anticipated X
Cadmium calcium copper
zinc sulfate chromate
12001-20-6
A2 Group 1 Known X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 2A - Probably Carcinogenic to Humans
Group 3 - Not Classifiable as to Carcinogenicity in Humans
NTP (National Toxicology Program)
Reasonably Anticipated - Reasonably Anticipated to be a Human Carcinogen
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive toxicity
Contains a known or suspected reproductive toxin. Product is or contains a chemical which
is a known or suspected reproductive hazard.
Developmental Toxicity
Contains ingredients that have suspected developmental hazards.
STOT - single exposure
No information available.
STOT - repeated exposure
No information available.
Chronic Toxicity
Chronic exposure to corrosive fumes/gases may cause erosion of the teeth followed by jaw
necrosis. Bronchial irritation with chronic cough and frequent attacks of pneumonia are
common. Gastrointestinal disturbances may also be seen. Contains a known or suspected
carcinogen. Contains a known or suspected reproductive toxin. Possible risk of irreversible
effects. May cause adverse effects on the bone marrow and blood-forming system. May
cause adverse liver effects. Lead compounds may be absorbed by ingestion, by inhalation
and through the skin. Lead may damage kidney function, the blood forming system and the
reproductive system.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Reproductive System. Blood.
Central Nervous System (CNS). Central Vascular System (CVS). Kidney. Liver.
Cardiovascular system. May damage the unborn child.
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral)
266.00 mg/kg
ATEmix (dermal)
436.00 mg/kg
ATEmix (inhalation-gas)
4,132.00 ppm
ATEmix (inhalation-dust/mist)
1.64 mg/l
ATEmix (inhalation-vapor)
13.33 ATEmix
_____________________________________________________________________________________________
Page 9 / 14